Heron Therapeutics (AXD2) Q2 2023 Earnings Report
4 Followers
DE:AXD2 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.31
- Consensus EPS
- -EUR 0.20
- Beat/Miss
- Missed by -EUR 0.11
- One Year Ago EPS
- -EUR 0.49
DE:AXD2 Q2 2023 Revenue Results
- Actual Revenue
- EUR 28.33M
- Expected Revenue
- EUR 28.27M
- Beat/Miss
- Beat by +EUR 58.88K
- YoY Revenue Growth
- +14.95%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- After Close
- Conference Call
- Monday, August 14, 2023
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:AXD2 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2026 (Q3) | -0.02- | -0.09 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.12) | |
| Aug 06, 2024 | 2024 (Q2) | -0.03-0.05 | -0.31 | 82.86% (+0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
